Complete remission of metastatic renal cell carcinoma to the bone with sunitinib

Target agents such as tyrosine kinase inhibitors have improved renal cell carcinoma (RCC) patient outcomes. However, complete remission (CR) with target agents is rare. Furthermore, CR of bone metastasis is much less common. We report a case of CR in bone and lung metastatic RCC. Radical nephrectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Akihiro, Nakata, Wataru, Yamamichi, Gaku, Tsujimura, Go, Tsujimoto, Yuichi, Nin, Mikio, Tsujihata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184521/
https://www.ncbi.nlm.nih.gov/pubmed/32368498
http://dx.doi.org/10.1016/j.eucr.2020.101213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184521/
https://www.ncbi.nlm.nih.gov/pubmed/32368498
http://dx.doi.org/10.1016/j.eucr.2020.101213

Ejemplares similares